78 related articles for article (PubMed ID: 3608720)
1. [Fibrinolytic activity and coronary heart disease].
Yao SK; Chen ZJ; Tao SQ
Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):71-3, 124. PubMed ID: 3608720
[No Abstract] [Full Text] [Related]
2. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
3. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
[TBL] [Abstract][Full Text] [Related]
4. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
[No Abstract] [Full Text] [Related]
5. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinolytic activity following oral anabolic steroid therapy.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):236-45. PubMed ID: 1103357
[TBL] [Abstract][Full Text] [Related]
7. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
8. [The significance of plasma D-dimer contents in patients with coronary heart disease].
Huang C; Xu M; Zhao Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):551-2. PubMed ID: 10073007
[No Abstract] [Full Text] [Related]
9. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
Dudaev VA; Diukov IV; Borodkin VV
Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinolytic system in patients with nephrotic syndrome].
Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
[No Abstract] [Full Text] [Related]
11. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
Ikonnikova EI; Katkova NB; Filippova SB
Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
[No Abstract] [Full Text] [Related]
15. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
[TBL] [Abstract][Full Text] [Related]
16. [Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Revutskiĭ EL; Palamarchuk VI; Vendt VP; Fedorishko SS
Vrach Delo; 1979 Sep; (9):43-5. PubMed ID: 494607
[No Abstract] [Full Text] [Related]
17. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease.
Kruskal JB; Commerford PJ; Franks JJ; Kirsch RE
N Engl J Med; 1987 Nov; 317(22):1361-5. PubMed ID: 3683469
[TBL] [Abstract][Full Text] [Related]
18. [Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
Olszewski W; Laskowski S; Jeziorny J; Kogucki S
Pol Tyg Lek; 1968 Dec; 23(49):1885-7. PubMed ID: 5704215
[No Abstract] [Full Text] [Related]
19. [The importance of the fibrinolytic system for the detection of thrombosis susceptiblility].
Klöcking HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):238-47. PubMed ID: 50990
[No Abstract] [Full Text] [Related]
20. Fibrinolysis in patients with ischemic heart disease (in relation to the etiologic factor of myocardial infarction).
Sassa H; Ito T; Niwa T; Matsui E
Jpn Circ J; 1975 May; 39(5):525-30. PubMed ID: 125352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
